Concepedia

Author

Joseph I. Clark

Loyola University Medical CenterORCID

Also Known As

David F. McDermott, J B FELL, J CLARK, J Clark, J I Clark, J. Clark, J. I. Clark, J.C. Clark, J.I. Clark, J.W. Clark

173

Publications

26K

Citations

46

H-Index

71

Concepts

All Affiliations

Loyola University Medical CenterLoyola University ChicagoDana-Farber Cancer InstituteBeth Israel Deaconess Medical CenterProvidence Portland Medical Center
JI

About

Joseph I. Clark is an author at Loyola University Medical Center specializing in medicine, oncology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

25

34

4.6K

2

Health Sciences

7

7

1.1K

3

Cell Biology

5

5

538

4

Public Health

1

1

15

5

Allergy

1

1

15

Joseph I. Clark

×

77

Publications

24.8K

Citations

42

H-Index

YearCitations

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

F. Stephen Hodi, Steven O’Day, David F. McDermott,

New England Journal of Medicine

2010

14.9K

Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer

Bond Almand, Joseph I. Clark, Ekaterina Nikitina,

The Journal of Immunology

2001

1.3K

Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial

Kim Margolin, Marc S. Ernstoff, Omid Hamid,

The Lancet Oncology

2012

1.1K

Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma

David F. McDermott, Meredith M. Regan, Joseph I. Clark,

Journal of Clinical Oncology

2004

814

Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial

Robert I. Haddad, Anne O’Neill, Guilherme Rabinowits,

The Lancet Oncology

2013

735

Clinical significance of defective dendritic cell differentiation in cancer.

Bond Almand, John R. Resser, Brian R. Lindman,

PubMed

2000

700

Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders

Douglas B. Johnson, Ryan J. Sullivan, Patrick A. Ott,

JAMA Oncology

2015

653

Concurrent Cisplatin, Etoposide, and Chest Radiotherapy in Pathologic Stage IIIB Non–Small-Cell Lung Cancer: A Southwest Oncology Group Phase II Study, SWOG 9019

Kathy S. Albain, John J. Crowley, Andrew T. Turrisi,

Journal of Clinical Oncology

2002

343

Adjuvant High-Dose Bolus Interleukin-2 for Patients With High-Risk Renal Cell Carcinoma: A Cytokine Working Group Randomized Trial

Joseph I. Clark, Michael B. Atkins, Walter J. Urba,

Journal of Clinical Oncology

2003

311

Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study

Ezra E.W. Cohen, Darren W. Davis, Theodore Karrison,

The Lancet Oncology

2009

271

Page 1